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Vinculin is a central component of mechanosensitive adhesive complexes that
form between cells and the extracellular matrix. A myriad of infectious
agents mimic vinculin binding sites (VBS), enabling them to hijack the adhe-
sion machinery and facilitate cellular entry. Here, we report the structural
and biochemical characterisation of VBS from the chlamydial virulence factor
TarP. Whilst the affinities of isolated VBS peptides from TarP and talin for
vinculin are similar, their behaviour in larger fragments is markedly different.
In talin, VBS are cryptic and require mechanical activation to bind vinculin,
whereas the TarP VBS are located in disordered regions, and so are constitu-
tively active. We demonstrate that the TarP VBS can uncouple talin:vinculin
complexes, which may lead to adhesion destabilisation.
Keywords: adhesion; chlamydia; crystallography; molecular mimicry;
talin; vinculin
Interactions between cells and the surrounding extra-
cellular matrix (ECM), mediated via the integrin fam-
ily of cell adhesion molecules, are fundamental to the
development of multicellular life. These adhesions
serve not just as attachment points but also as
mechanosensitive signalling hubs, enabling cells to
sense and respond to the external environment. Inte-
grin receptors bound to ECM are coupled to the actin
cytoskeleton via the mechanosensitive protein talin [1].
Under force, helical bundles in the talin rod domain
unfold, exposing multiple cryptic vinculin binding sites
(VBS) [2,3] that bind to the vinculin head (Vd1), acti-
vating autoinhibited vinculin by displacing the vinculin
tail [4] (Fig. 1A). Activation of talin and vinculin also
exposes numerous other cryptic binding sites for
ligands that affect the assembly and regulation of both
cell:ECM focal adhesions (FAs) and cell:cell junctions
[5,6].
These highly conserved attachment points linking
the cell to the outside world have also become
recognition sites for numerous infectious agents [7,8]
with some bacteria specifically targeting adhesion pro-
teins for cellular entry. It has previously been shown
that the Shigella flexneri effector protein IpaA [9] and
the Rickettsia cell surface antigen Sca4 interact with
vinculin [10]. The atomic structures of these virulence
factors reveal mimicry of the talin VBS. Thus, by
forming amphipathic a-helices that bind to Vd1, these
virulence factors activate autoinhibited vinculin and
hijack cell adhesion to aid pathogenesis.
Chlamydia invasion has been shown to require the
effector protein translocated actin recruiting protein
(TarP) which is thought to play an important role in
actin recruitment [11,12]. TarP is translocated into the
host cell by a chlamydial type 3 secretory system upon
early elementary body (EB) attachment to the host
cell. TarP injection by the bacteria leads to the recruit-
ment and bundling of actin filaments at the point of
invasion [12]. Recently, Thwaites et al. reported the
presence of a vinculin binding region in TarP,
Abbreviations
FP, fluorescence polarisation; HSQC, heteronuclear single quantum coherence; LD-motif, leucine-aspartic acid motif; TarP, translocated actin
recruitment protein; VBS, vinculin-binding site.
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Fig. 1. Biochemical characterisation of the TarP interaction with the vinculin head (Vd1). (A) Schematic of talin structure, with the location of
the 11 talin VBS indicated (purple). (B) Schematic of TarP, indicating locations of VBS1 (green), VBS2 (orange), VBS3 (yellow), Actin binding
site ABS (red) and LD-motif (blue) at the C-terminal. The disorder prediction trace generated using DISOPRED3 [44] is shown. (C) Multiple
sequence alignment of vinculin binding sites, aligned using Clustal Omega. The consensus residues are highlighted in green. (D)
Comparison of the Vd1:TarP and Vd1:talin interactions. Binding of fluorescein labelled talin VBS33, VBS36, TarP VBS (850–868)C and LD
(655–680)C peptides to Vd1, measured using a fluorescence polarisation assay. Dissociation constants  SE (lM) for the interactions are
indicated in the legend. All measurements were performed in triplicate. ND, not determined.
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containing three vinculin binding sites (VBS) with
‘VBS1’ being essential for vinculin recruitment [13].
Additionally, TarP was reported to contain a Leucine-
Aspartic acid motif (LD-motif) with a similar consen-
sus sequence to the second paxillin LD-motif (LD2)
which interacts with focal adhesion kinase (FAK) [14],
and thus may provide TarP with a means of engaging
FAK and altering cell adhesion signalling.
Here, we report the structure of the TarP:vinculin
Vd1 complex and biochemically characterise and com-
pare the interaction of the TarP VBS and talin VBS
with vinculin. Whilst the affinities of the isolated VBS
from TarP and talin are similar, their behaviour in lar-
ger polypeptide fragments is very different. Thus, the
TarP VBS are positioned in unstructured regions, and
TarP VBS1 is constitutively active whilst the talin VBS
are buried inside folded rod domains and are cryptic.
Furthermore, we demonstrate TarP VBS1 disrupts
talin:vinculin complexes in vitro. This ability to uncou-
ple vinculin from talin suggests that TarP and other
virulence factors may have the capacity to trigger FA
disassembly during invasion.
Materials and methods
Expression of recombinant polypeptides
Chicken vinculin Vd1 (residues 1–259), murine talin R10
(residues 1815–1973), and the FAK-FAT domain (residues
941–1090) were cloned into a pET151 vector (Invitrogen)
and expressed in E .coli BL21 (DE3) cells cultured in LB.
Standard nickel-affinity chromatography was used to purify
the His-tagged recombinant proteins as described previ-
ously [15]. The proteins were further purified using anion-
exchange chromatography following cleavage of the 6xHis-
tag with TEV protease. Protein concentrations were deter-
mined using the respective extinction coefficients at
280 nm.
Fluorescence polarisation assays
Peptides with either a C- or N-terminal cysteine were syn-
thesised by GLBiochem (China).
TarP_VBS1 (LLEAARNTTTMLSKTLSKV-C;
C. caviae residues 850–868)
TarP_LD (EGAEGLEHLLPQLRSHLDDAFDQQGN-
C; C. caviae residues 655–680)
Pax_LD2 (C-NLSELDRLLLELN; paxillin residues 141–
153)
Pax_LD4 (C-ATRELDELMASLS; paxillin residues
262–274)
mTal1_VBS33 (C-ASARTANPTAKRQFVQSAKE-
VANSTANLVKTIKAL; talin residues 1512–1546)
mTal1_VBS36 (C-VNPRDPPRWSVLAGHSRTVSD-
SIKKLITSMRDKAP; talin residues 1622–1656)
Peptides were coupled to a thiol-reactive fluorescein dye
via the terminal cysteine. Stock solutions were made in
phosphate-buffered saline (PBS; 137 mM NaCl, 27 mM
KCl, 100 mM Na2HPO4, 18 mM KH2PO4, pH 7.4), 1 mM
TCEP and 0.05% Triton X-100. Excess dye was removed
using a PD-10 desalting column (GE Healthcare, Chicago,
IL, USA). Titrations were performed in PBS using a con-
stant 1 lM concentration of fluorescein-coupled peptide
with increasing concentration of protein; final volume
100 lL in a black 96-well plate. Fluorescent polarisation
(FP) measurements were recorded on a BMGLabTech
CLARIOstar plate reader at room temperature and anal-
ysed using GraphPad Prism. Kd values were calculated with
nonlinear curve fitting using a one-site total binding model.
Analytical gel filtration
Gel filtration was performed using a Superdex-75 size-
exclusion chromatography column (GE healthcare) at a
flow rate of 1 mLmin1 at 4 °C in 50 mM Tris pH 7.5,
150 mM NaCl, 2 mM DTT. A sample of 100 lL was run
consisting of 100 lM of each protein/peptide, incubated at
a 1 : 1 (talin:Vd1) or 1 : 1 : 1 (talin:Vd1:TarP VBS1/talin
VBS36) ratio, at 37 °C for 30 min. In the competition
experiment, an additional 30 nM of fluorescein-coupled
TarP peptide was added to visualise the TarP elution via
absorbance at 494 nm. The elution absorbance was mea-
sured at three wavelengths: 220 nm, 280 nm and 494 nm
(fluorescein absorbance). Elution was monitored by a
Malvern Viscotek SEC-MALS-9 (Malvern Panalytical,
Malvern, UK). Molar mass, refractive index and weight
fraction (%) were determined using the OmniSEC software
(Malvern Panalytical) and statistical significance assessed
using a T-test.
X-ray crystallography
Crystallisation trials for Vd1 in the presence of TarP VBS
peptide were conducted at 21 °C by hanging drop vapour
diffusion while maintaining a 1 : 1 protein to peptide ratio.
Crystals were obtained in a condition containing 0.1 M
sodium citrate tribasic dehydrate pH 5.6 and 20% v/v 2-
propanol. Crystals were cryoprotected in the same solution
supplemented with 20% v/v glycerol prior to vitrification in
liquid nitrogen. Diffraction dataset was collected at 100 K
on beamline I03 at Diamond Light Source (Didcot, UK)
using a Pilatus3 6M detector (Dectris, Baden, Switzerland).
Crystallographic data were processed by autoPROC [16],
which incorporates XDS [17], AIMLESS [18] and TRUN-
CATE [19] for data integration, scaling and merging. Struc-
ture of the Vd1/TarP complex was determined using
chicken vinculin head as template (PDB: 3ZDL [20]) for
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molecular replacement search carried out with PHASER
[21]. Manual model adjustment and refinement were per-
formed with COOT [22] and REFMAC [23] respectively.
Model was validated with MOLPROBITY [24] and interac-
tion properties were determined by PISA [25]. Figure prepa-
ration was carried out with PYMOL (Schr€odinger LLC,
Cambridge MA, USA). For data collection, phasing and
refinement statistics, Table 1. The structure has been depos-
ited to RCSB Protein Data Bank with accession code
6FQ4.
NMR Spectroscopy
NMR spectra were obtained using a Bruker AVANCE III
600 MHz spectrometer equipped with CryoProbe. Experi-
ments were performed at 298 K in 20 mM sodium phos-
phate pH 6.5, 50 mM NaCl, 2 mM DTT with 5% (v/v)
2H2O. Ligand binding was evaluated from
1H,15N-HSQC
chemical shift changes using 130 lM 15N-labelled FAK-
FAT domain. Peptides were added at a 3 : 1 peptide:pro-
tein ratio.
Results
Chlamydial VBS interacts with vinculin
It has previously been shown that the interaction
between TarP and vinculin is required for Chlamydia
infection [13]. TarP was shown to contain three VBS
with only the C-terminal VBS, VBS1, being critical for
TarP function (Fig. 1B). Multiple sequence alignment
with the VBS of talin (Fig. 1C) confirmed the region
that contains the vinculin head domain (Vd1) consen-
sus binding motif LxxAAxxVAxxVxxLIxxA [26] as
reported previously [13].
To evaluate how the interaction of Vd1 with the
TarP VBS1 compares to its interaction with talin VBS,
we measured the relative binding affinities using an
in vitro fluorescence polarisation (FP) assay. In this
assay, synthetic VBS peptides (Materials and methods)
were fluorescently labelled with fluorescein and titrated
against an increasing concentration of Vd1. Binding of
the VBS peptide to Vd1 results in an increase in fluo-
rescence polarisation (Fig. 1D), which can be used to
determine the binding constant, Kd. The TarP VBS1
peptide bound to Vd1 with an affinity of 1.29 lM. The
talin VBS located on talin helices, 33 and 36 (VBS33
and VBS36), bound with comparable affinities of
0.34 lM and 1.03 lM respectively (Fig. 1D). The TarP
LD region (residues 655–680), which does not interact
with Vd1, was used as a negative control.
Although the affinity of the TarP VBS1 for vinculin
is comparable to the VBS in talin, the location of the
VBS are markedly different between the two proteins.
Talin VBS are maintained in a cryptic conformation,
buried inside the hydrophobic core of the talin rod
domain bundles [27], and require exposure by mechan-
ical force across talin to unfold the bundles [3,28]. In
contrast, the VBS in TarP are situated in disordered
regions of the molecule and are therefore likely to be
constitutively active (Fig. 1B). The affinity of talin
VBS in folded rod domains for Vd1 is significantly
lower due to the energy required to unfold the domain
to expose the VBS [29]. However, this reduced affinity
of talin for vinculin is rapidly overcome by force
exerted on talin, an effect that is readily reversible
when force is removed, meaning that the talin:vinculin
interactions are exquisitely force-dependent [28].There-
fore, in the absence of mechanical force, TarP has the
potential to outcompete folded talin to bind vinculin.
Table 1. X-ray data collection and refinement statistics for TarP-
Vd1 complex. Data collected from a single crystal.
Data collection




a, b, c (A) 51.80, 66.87, 95.83
a, b, c (°) 90, 90, 90

















Bond lengths (A) 0.010






Protein geometry 3.42 (37th)b
Clash score all atoms 29 (81st)b
PDB accession no. 6FQ4
aValues in parentheses are for highest-resolution shell.
bValues in parentheses indicate percentile scores as determined by
Molprobity.
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The structure of TarP VBS1 in complex with the
vinculin head
To further characterise the interaction between TarP
VBS1 and vinculin, we crystallised a complex of TarP
(850–868) with vinculin Vd1. The crystals containing
one molecule of the complex in the asymmetric unit
were in orthorhombic space group P21212 and dif-
fracted to a useful resolution of 2.9 A.
The structure of the complex was determined by
molecular replacement (Fig. 2A; statistics in Table 1)
and shows good agreement with the complexes of Vd1
with other VBS from talin [4,30], sca-4 [31] and IpaA
[32]. The TarP VBS1 forms an a-helix that embeds
into the hydrophobic groove formed between a-helices
1 and 2 of the Vd1 N-terminal 4-helix bundle, forming
a structure that resembles a five-helix bundle (Fig. 2B).
Analysis of the complex interface by PISA indicated
that 54.1% of the VBS surface area, including the con-
sensus residues, is buried in the complex interface
(Fig. 2A). Furthermore, two hydrogen bonds were
identified: TarP Arg-855 to Vd1 Ser-11, and TarP Ser-
862 to Vd1 Gln-18. Structural alignment of known
VBS structures indicates that these hydrogen bonds
are well conserved. Upon complex formation, TarP
significantly alters the positions of Vd1 helices 1 and 2,
widening the groove between the two and exposing the
hydrophobic core (Fig. 2C), mimicking the way talin
activates vinculin, causing the release of the vinculin
tail [4,33]. With sidechains almost identical in length
and character to talin VBS, TarP VBS1 is able to pack
tightly into the Vd1 hydrophobic groove accounting
for the high affinity we measured (Fig. 1C). The strong
resemblance of the TarP VBS1 to the VBS in talin
demonstrates the molecular mimicry employed by
TarP to hijack the host cell adhesion machinery.
The TarP peptide competes with talin for binding
to vinculin
Since TarP VBS1 binds to the same site on vinculin as
the talin VBS, this raises the possibility that TarP
binding might compete with talin for vinculin binding.
A similar phenomenon was seen in Drosophila
recently, where expression of a GFP-VBS construct
was found to disrupt talin:vinculin interactions in vivo
[34]. Using analytical gel filtration, we measured the
interaction between Vd1 and a VBS-containing talin
helical bundle. We selected talin rod domain R10,
which contains a single VBS (VBS46) [35]. Equimolar
amounts of Vd1 and talin R10 incubated together at
37 °C formed a 1 : 1 complex (Fig. 3A-B). Adding a
stoichiometric amount of TarP VBS1 peptide
(Fig. 3A), or a peptide of an isolated talin VBS
(VBS36; Fig. 3B) resulted in a significant reduction in
the talin:Vd1 peak and concomitant increases in the
monomer peaks of the respective proteins. To confirm
that disruption of the talin:Vd1 complex was due to
competition by the TarP VBS1 peptide, we spiked the
TarP VBS1 peptide with 30 nM of fluorescein-TarP
VBS1 peptide (as used in the FP assay). The fluores-
cein-coupled TarP VBS1 eluted in the same fractions
as Vd1, confirming that the TarP peptide was bound
to Vd1. To quantitate this competition, we used the
SEC-MALS OmniSEC software to determine the
weight fraction (%) of each peak in Fig. 3A-B and this
analysis is shown in Fig. 3C. This demonstrates that
TarP, and exposed VBS in general, can out-compete
talin for binding to Vd1 in vitro even when the vin-
culin:talin complex is already formed. Whilst the iso-
lated talin VBS and TarP VBS1 peptides have similar
affinities, the affinity of Vd1 for the intact talin rod
domain is reduced significantly due to the cryptic nat-
ure of talin VBS in the folded talin helical bundles
[29]. As a consequence, the constitutively active nature
of the TarP VBS allows it to disrupt vinculin:talin
complexes. Vinculin binding to talin inhibits talin
refolding [28] and is important for FA stabilisation.
TarP disruption of this complex could lead to the loos-
ening of adhesion by disrupting the talin:vinculin:actin
cytoskeletal connection. This may mean that, as well
as providing a means of entry and a mechanism to
hijack the actin machinery, infection might also desta-
bilise FAs at the point of entry.
The TarP leucine-aspartic acid motif
Leucine-Aspartic acid motifs (LD-motifs) are well-
recognised protein:protein interaction motifs [36], first
identified in the FA protein paxillin, and shown to be
required for paxillin to interact with focal adhesion
kinase (FAK) [37]. The FAK–paxillin interaction was
subsequently mapped to the focal adhesion targeting
(FAT) domain of FAK [38]. It was reported previously
that TarP contains an LD-motif (residues 655–680;
TarP LD-motif) with sequence homology to paxillin
LD2 [14], and that this LD-motif interacts with the
FAK-FAT domain and plays a role in actin recruit-
ment. The alignment of the TarP LD-motif with the
LD domains in KANK1 [39], RIAM [40], DLC1 [20]
and the paxillin LD1 and LD2 motifs are shown in
Fig. 4A. To investigate the interaction of TarP LD-
motif with FAK, we used the FP assay utilising fluo-
rescein-labelled LD-motif peptides, and measured their
binding to the FAK-FAT domain. As expected, pax-
illin LD2 bound well to the FAK-FAT domain
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(Kd ~ 9 lM) in line with previous reports [38]. How-
ever, we observed no increase in polarisation with the
TarP LD-motif, suggesting that any interaction
between TarP and FAK is too weak to be detected by
the FP assay.
NMR is a powerful technique for studying interac-
tions, even very weak (millimolar Kd) interactions.
Addition of paxillin LD2 peptide to 15N-labelled
FAK-FAT resulted in large chemical shift changes
indicative of a robust interaction (Fig. 4C). In con-
trast, addition of a threefold excess of TarP LD-motif
resulted in only very small shift changes, suggesting
the peptide interacts only very weakly with FAK-FAT
(Kd > mM). This weak interaction explains the lack of
Fig. 2. Crystal structure of TarP in complex with Vd1. (A) Cartoon representation of the complex of Vd1 (grey) bound to TarP VBS (green);
the consensus VBS residues are shown in red. (B) TarP VBS (green) docks into a hydrophobic groove on Vd1. Vd1 is represented as surface
coloured by hydrophobicity: hydrophobic = red, hydrophilic = white. (C) TarP VBS peptide (green) aligned with talin VBS46 peptide (purple,
PDB:1RKC [4]) with Vd1-interacting sidechains from both VBS shown as sticks and TarP residues (top bold) and corresponding vbs46
residues are shown. (D) VBS binding causes conformational change in the Vd1 domain. Comparison of apo Vd1 (cyan, PDB:1TR2 [45]) and
TarP bound Vd1 (grey). The TarP peptide is shown as a ribbon (green).
Fig. 3. TarP VBS disrupts the interaction between talin R10 and vinculin Vd1. Vd1 was incubated with talin R10 at 37 °C for 30 min then
analysed on a gel filtration column (grey). The experiment was repeated with the addition of a stoichiometric amount of TarP VBS peptide
(A) and then with talin VBS36 (B). All experiments were done in triplicate. 1% fluorescein-labelled TarP VBS peptide was added to monitor
TarP VBS elution at 494 nm which confirmed that TarP eluted bound to Vd1 (purple). (C) the relative ‘Weight Fraction’ percentage for talin:
vinculin complex, talin, vinculin peaks in the absence and presence of both TarP VBS and VBS36 peptides. Data are means  SEM;
*P < 0.05 by T-test. Both peptides reduced the R10-Vd1 complex.
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binding in the FP experiment. The difference in bind-
ing affinity between the TarP LD-motif and paxillin
LD2 to FAK-FAT may be explained by the presence
of a proline residue, Pro675, in the middle of the TarP
LD-motif (Fig. 4A). It is likely the proline destabilises
and/or causes a kink in the a-helix formed by the TarP
LD-motif, but lack of binding might also be due to
the substitution of glutamate for aspartate in the ‘LD’
region of the TarP LD-motif. Therefore, despite the
sequence homology, the TarP LD-motif binds much
weaker than paxillin-LD2 to FAK-FAT, further refin-
ing the specificity determinants of LD-motifs and high-
lighting the fact that subtle changes in the sequence
can significantly alter binding specificity.
It is possible that the TarP LD-motif may bind to
another, currently unrecognised LD-binding domain
protein, but it does not bind to FAK. Therefore, it
seems likely that the TarP:FAK colocalisation
reported previously in cellulo requires additional com-
ponents that bring FAK and TarP together.
Conclusions
In this study, we have further refined understanding of
the molecular mechanisms underlying chlamydial infec-
tion via remodelling of the actin cytoskeleton; the ability
of TarP to bind vinculin characterised here, and the
recently characterised TarP WH2 motif that binds actin
[41], look to be major components. Our data show that
the constitutively active TarP VBS1 can out-compete
the mechanosensitive interaction between talin and vin-
culin. Vinculin is a key player in the regulation of FA
dynamics [42] and cell:cell junctions [43], and the capac-
ity of TarP VBS1 to uncouple vinculin-mediated
cytoskeletal connections during infection is therefore
likely to have significant biological implications. Thus,
it will be important to determine to what extent chlamy-
dial infection alters the integrity and dynamics of cell:-
cell and cell:ECM junctions. Moreover, it raises the
possibility that endogenous mammalian proteins might
exist with constitutively active VBS, and that these
could represent a new class of protein with the ability to
regulate cell adhesion and migration.
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